drug
glimepiride
Marketedupdated 3mo agoby Carlsbad Technology Inc
Approvedcommunity read0 votes
indications
investigational
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying glimepiride
- phase4Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
- phase3Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure
- phase4A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
- phase1Glimepiride 4 mg Tablets Under Non-Fasting Conditions
- phase1Glimepiride 4 mg Tablets Under Fasting Conditions
- phase1Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg
- phase1Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg
- N/AImpact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that